We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




First-Of-Its-Kind Tool Analyzes MRI Scans to Measure Brain Aging

By HospiMedica International staff writers
Posted on 25 Feb 2025

Biological age differs from chronological age, as two individuals of the same age may have distinct biological ages based on the functionality of their bodies and how the tissues appear at a cellular level. More...

Faster brain aging is strongly linked to an increased risk of cognitive decline. Common biological age measures often rely on blood samples to assess epigenetic aging and DNA methylation, which affects gene function in cells. However, using blood samples to gauge biological age is ineffective for determining brain age. The blood-brain barrier prevents blood cells from entering the brain, meaning that blood samples cannot directly reflect aging processes such as DNA methylation in the brain. On the other hand, obtaining a sample directly from the brain is highly invasive, making it impractical to measure DNA methylation and other aging indicators from living human brain cells. Now, researchers have developed a new artificial intelligence (AI) model capable of non-invasively measuring the speed of brain aging, providing an invaluable tool for understanding and addressing cognitive decline and dementia. This innovative model analyzes magnetic resonance imaging (MRI) scans to track brain changes.

Earlier research at the USC Leonard Davis School of Gerontology (Los Angeles, CA, USA) revealed the potential of MRI scans to estimate brain biological age without invasive methods. In earlier studies, AI was used to compare a patient’s brain structure with data from MRI scans of thousands of individuals, assessing various ages and cognitive health outcomes. However, the previous model had limitations, as it relied on a single MRI scan to estimate brain age. Although it could indicate whether a patient’s brain was older than their chronological age, it could not determine when the accelerated aging occurred or whether the brain aging process was speeding up.

The researchers have developed a new three-dimensional convolutional neural network (3D-CNN) that offers a more accurate method to measure brain aging over time. Trained and validated on more than 3,000 MRI scans from cognitively normal adults, the model's predictive ability was detailed in a study published in the Proceedings of the National Academy of Sciences. Unlike traditional methods that rely on one-time scans, this new longitudinal approach compares baseline and follow-up MRI scans of the same person. This allows for a more precise identification of neuroanatomic changes associated with faster or slower brain aging. The 3D-CNN also produces “saliency maps,” which highlight the specific brain regions that most significantly influence aging speed.

When applied to 104 cognitively healthy adults and 140 Alzheimer’s disease patients, the model’s assessment of brain aging speed showed a close correlation with changes in cognitive function tests at both time points. The researchers suggest that this model could be instrumental in better understanding the trajectories of both healthy aging and neurodegenerative diseases. Moreover, its predictive capabilities could help identify the most effective treatments tailored to individual characteristics. The new model was also able to differentiate the rates of aging in various brain regions, providing insight into how genetic, environmental, and lifestyle factors may influence brain pathology.

The study also noted differences in brain aging between the sexes, which may help explain why men and women face different risks for neurodegenerative diseases, such as Alzheimer’s. The researchers are particularly excited about the potential of this new model to identify individuals experiencing accelerated brain aging before they exhibit any cognitive symptoms. With the introduction of new Alzheimer’s treatments, their effectiveness has been less than expected, possibly because patients have not begun treatment until significant brain pathology has already developed.

“This is a novel measurement that could change the way we track brain health both in the research lab and in the clinic,” said Andrei Irimia, associate professor of gerontology, biomedical engineering, quantitative & computational biology and neuroscience at the USC Leonard Davis School of Gerontology. “Knowing how fast one’s brain is aging can be powerful.”

Related Links:
USC Leonard Davis School of Gerontology


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Emergency Department Campaign Reduces CT Use Without Identified Missed Injuries

Unnecessary head and cervical spine computed tomography (CT) in low-risk trauma patients exposes them to avoidable radiation, prolongs emergency department stays, and increases healthcare costs.... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.